Valeant Pharmaceuticals To Hold Investor Conference Call On October 26, 2015

Go back to Valeant Pharmaceuticals To Hold Investor Conference Call On October 26, 2015

SEC Won't Comment on Speculation of Valeant Pharmaceuticals (VRX) Probe

October 22, 2015 3:43 PM EDT

The SEC would not comment to StreetInsider.com on speculation that it is investigating Valeant Pharmaceuticals (NYSE: VRX) amid allegations related to its relationship with Philidor and R&O, accounting practices, and channel stuffing. "As per our policy, we can not confirm or... More

Valeant Pharma (VRX) to Hold Investor Conference Call on October 26

October 22, 2015 2:39 PM EDT

Valeant Pharma (NYSE: VRX) today announced that it will host a conference call and a live webcast along with a slide presentation on Monday, October 26, 2015 at 8:00 a.m. ET (5:00 a.m. PT). The purpose of the call will be to lay out the facts including allegations made against our company regarding our relationship with Philidor and R&O, our accounting practices, and channel stuffing that contain numerous errors, unsupported speculation and incorrect... More

Valeant Pharma (VRX) Will Hold Investor Conf. Call on Oct. 26th

October 22, 2015 2:39 PM EDT

Valeant Pharma (NYSE: VRX) announced that it will host a conference call and a live webcast along with a slide presentation on Monday, October 26, 2015 at 8:00 a.m. ET (5:00 a.m. PT). The purpose of the call will be to lay out the facts including allegations made against our company regarding our relationship with Philidor and R&O, our accounting practices, and channel stuffing that contain numerous errors, unsupported speculation and incorrect interpretations of... More